DE69840175D1 - Biologisch abbaubare gemischte polymerische mizellen zur genverabreichung - Google Patents
Biologisch abbaubare gemischte polymerische mizellen zur genverabreichungInfo
- Publication number
- DE69840175D1 DE69840175D1 DE69840175T DE69840175T DE69840175D1 DE 69840175 D1 DE69840175 D1 DE 69840175D1 DE 69840175 T DE69840175 T DE 69840175T DE 69840175 T DE69840175 T DE 69840175T DE 69840175 D1 DE69840175 D1 DE 69840175D1
- Authority
- DE
- Germany
- Prior art keywords
- polymeric micelles
- mixed polymeric
- generic administration
- biodegradable mixed
- biodegradable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
- Y10S977/916—Gene therapy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6955197P | 1997-12-12 | 1997-12-12 | |
PCT/US1998/026403 WO1999029303A1 (en) | 1997-12-12 | 1998-12-11 | Biodegradable mixed polymeric micelles for gene delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69840175D1 true DE69840175D1 (de) | 2008-12-11 |
Family
ID=22089740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69840175T Expired - Lifetime DE69840175D1 (de) | 1997-12-12 | 1998-12-11 | Biologisch abbaubare gemischte polymerische mizellen zur genverabreichung |
Country Status (13)
Country | Link |
---|---|
US (1) | US6210717B1 (de) |
EP (1) | EP1037611B1 (de) |
JP (1) | JP4570776B2 (de) |
KR (1) | KR20010032878A (de) |
CN (1) | CN1281355A (de) |
AR (1) | AR018528A1 (de) |
AT (1) | ATE412403T1 (de) |
AU (1) | AU740342B2 (de) |
BR (1) | BR9813548A (de) |
DE (1) | DE69840175D1 (de) |
IL (1) | IL136681A0 (de) |
WO (1) | WO1999029303A1 (de) |
ZA (1) | ZA9811376B (de) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002500201A (ja) * | 1998-01-05 | 2002-01-08 | ユニバーシティ オブ ワシントン | 膜破壊剤を使用する増強された輸送 |
SE9904581D0 (sv) * | 1999-12-15 | 1999-12-15 | A & Science Invest Ab | A novel helicobacter pylori-binding substance and use thereof |
WO2001051092A2 (en) * | 2000-01-07 | 2001-07-19 | University Of Washington | Enhanced transport of agents using membrane disruptive agents |
US20030134420A1 (en) * | 2000-02-18 | 2003-07-17 | Lollo Charles Peter | Methods and compositions for gene delivery |
US20030072794A1 (en) * | 2000-06-09 | 2003-04-17 | Teni Boulikas | Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes |
JP2003535832A (ja) * | 2000-06-09 | 2003-12-02 | ブリカス,テニ | ポリヌクレオチドおよび薬物の標的化リポソームへのカプセル化 |
TWI246524B (en) | 2001-01-19 | 2006-01-01 | Shearwater Corp | Multi-arm block copolymers as drug delivery vehicles |
US7265186B2 (en) * | 2001-01-19 | 2007-09-04 | Nektar Therapeutics Al, Corporation | Multi-arm block copolymers as drug delivery vehicles |
US20030157170A1 (en) * | 2001-03-13 | 2003-08-21 | Richard Liggins | Micellar drug delivery vehicles and precursors thereto and uses thereof |
AU2002240755B2 (en) * | 2001-03-13 | 2007-07-05 | Angiotech International Ag | Micellar drug delivery vehicles and uses thereof |
DK1392254T3 (da) * | 2001-04-20 | 2007-07-02 | Univ British Columbia | Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler |
KR100566911B1 (ko) * | 2001-06-25 | 2006-04-03 | 주식회사 삼양사 | 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체 |
US7030127B2 (en) | 2001-06-29 | 2006-04-18 | Ethicon, Inc. | Composition and medical devices utilizing bioabsorbable polymeric waxes |
US7034037B2 (en) | 2001-06-29 | 2006-04-25 | Ethicon, Inc. | Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin |
US6967234B2 (en) | 2002-12-18 | 2005-11-22 | Ethicon, Inc. | Alkyd-lactone copolymers for medical applications |
US20030186916A1 (en) * | 2002-03-12 | 2003-10-02 | Lei Yu | Vector for transfection of eukaryotic cells |
US7326426B2 (en) | 2002-03-29 | 2008-02-05 | Ethicon, Inc. | Compositions and medical devices utilizing bioabsorbable liquid polymers |
US7005136B2 (en) | 2002-03-29 | 2006-02-28 | Ethicon, Inc. | Bone replacement materials utilizing bioabsorbable liquid polymers |
WO2003090807A1 (en) * | 2002-04-24 | 2003-11-06 | Poly-Med, Inc. | Multifaceted endovascular stent coating for preventing restenosis |
US7368125B2 (en) | 2002-06-05 | 2008-05-06 | Ethicon, Inc. | Amphiphilic polymers for medical applications |
AR037006A1 (es) * | 2002-06-20 | 2004-10-20 | S I G Sist S De Identificacion | Marcador de objetos a identificar consistente en al menos un fragmento de adn. |
US7026374B2 (en) | 2002-06-25 | 2006-04-11 | Aruna Nathan | Injectable microdispersions for medical applications |
US7101566B2 (en) | 2002-06-28 | 2006-09-05 | Ethicon, Inc. | Polymer coated microparticles for sustained release |
MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
GB0228525D0 (en) * | 2002-12-06 | 2003-01-15 | Univ Cambridge Tech | Polymers and their use |
US20040115226A1 (en) * | 2002-12-12 | 2004-06-17 | Wenji Li | Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same |
US6872799B2 (en) | 2002-12-18 | 2005-03-29 | Ethicon, Inc. | Functionalized polymers for medical applications |
US6866860B2 (en) | 2002-12-19 | 2005-03-15 | Ethicon, Inc. | Cationic alkyd polyesters for medical applications |
US7135523B2 (en) * | 2003-03-14 | 2006-11-14 | Industrial Technology Research Institute | Nanoscale helical microstructures and channels from chiral poly(L-lactide) block containing block copolymers |
ES2298738T3 (es) * | 2003-03-25 | 2008-05-16 | Biacore Ab | Metodo de inmovilizacion y kit para ello. |
SE0300805D0 (sv) * | 2003-03-25 | 2003-03-25 | Biacore Ab | Immobilization method and kit therefor |
US7309757B2 (en) * | 2003-06-20 | 2007-12-18 | Agency For Science, Technology And Research | Polymers for the delivery of bioactive agents and methods of their preparation |
US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
AU2004297533B2 (en) | 2003-10-24 | 2010-04-29 | Gencia Corporation | Methods and compositions for delivering polynucleotides |
US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
US20090208478A1 (en) * | 2003-10-24 | 2009-08-20 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
WO2005105040A2 (en) * | 2004-04-26 | 2005-11-10 | Micelle Products, Inc. | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
WO2005115457A2 (en) * | 2004-05-10 | 2005-12-08 | University Of Utah Research Foundation | Combined active and passive targeting of biologically active agents |
EP1848410A4 (de) * | 2005-02-17 | 2011-11-09 | Medivas Llc | Zusammensetzungen zur ausgabe von polymerteilchen und anwendungsverfahren dafür |
WO2007011802A1 (en) | 2005-07-18 | 2007-01-25 | Nektar Therapeutics Al, Corporation | Method for preparing branched functionalized polymers using branched polyol cores |
KR20080064827A (ko) | 2005-10-05 | 2008-07-09 | 도쿄 씨알오 가부시키가이샤 | 생체 적합성 블록 공중합체, 그 용도 및 제조법 |
US7718193B2 (en) * | 2006-03-16 | 2010-05-18 | University Of Washington | Temperature- and pH-responsive polymer compositions |
ATE533838T1 (de) * | 2006-11-29 | 2011-12-15 | Novozymes Inc | Verfahren zur verbesserten einführung von dna in bakterienzellen |
US7981688B2 (en) | 2007-03-08 | 2011-07-19 | University Of Washington | Stimuli-responsive magnetic nanoparticles and related methods |
JP5270884B2 (ja) * | 2007-09-03 | 2013-08-21 | 大阪瓦斯株式会社 | 分散剤およびこの分散剤を含むポリ乳酸系複合樹脂粒子 |
CN102083972B (zh) * | 2008-01-25 | 2013-03-06 | 金拓 | 由内源性携带氨基的单体形成的聚阳离子基因载体 |
MX2010012236A (es) | 2008-05-13 | 2011-06-20 | Univ Washington | Portador polimerico. |
US9339558B2 (en) | 2008-05-13 | 2016-05-17 | University Of Washington | Micellic assemblies |
JP5911723B2 (ja) | 2008-05-13 | 2016-04-27 | ユニヴァーシティ オブ ワシントン | 細胞内に送達するためのジブロックコポリマーおよびそのポリヌクレオチド複合体 |
EP2331069A4 (de) | 2008-08-22 | 2011-10-26 | Univ Washington | Heterogene polymere mizellen für intrazelluläre freisetzung |
BRPI0921357A2 (pt) | 2008-11-06 | 2016-06-21 | Phaserx Inc | copolímeros em multibloco |
US8822213B2 (en) | 2008-11-06 | 2014-09-02 | University Of Washington | Bispecific intracellular delivery vehicles |
JP2012511053A (ja) | 2008-12-08 | 2012-05-17 | ユニヴァーシティ オブ ワシントン | オメガ機能性化ポリマー、ジャンクション機能性化ブロック共重合体、およびラジカル連鎖延長重合 |
EP2201935B1 (de) * | 2008-12-26 | 2020-07-08 | Samyang Biopharmaceuticals Corporation | Polymere Mizellenzusammensetzung, die ein schlecht lösliches Arzneimittel enthält, und zugehöriges Herstellungsverfahren |
CN102264350A (zh) * | 2008-12-26 | 2011-11-30 | 株式会社三养社 | 包含水溶性差的药物的聚合胶束纳米粒子组合物的制备方法 |
WO2010114768A1 (en) * | 2009-03-30 | 2010-10-07 | Cerulean Pharma Inc. | Polymer-epothilone conjugates, particles, compositions, and related methods of use |
WO2010114770A1 (en) * | 2009-03-30 | 2010-10-07 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
CA2756072A1 (en) * | 2009-03-30 | 2010-10-14 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
US8426214B2 (en) * | 2009-06-12 | 2013-04-23 | University Of Washington | System and method for magnetically concentrating and detecting biomarkers |
US9080933B2 (en) | 2009-11-09 | 2015-07-14 | University Of Washington Through Its Center For Commercialization | Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates |
US20110117668A1 (en) * | 2009-11-09 | 2011-05-19 | University Of Washington Through Its Center For Commercialization | Self-powered smart diagnostic devices |
WO2011062965A2 (en) | 2009-11-18 | 2011-05-26 | University Of Washington Through Its Center For Commercialization | Targeting monomers and polymers having targeting blocks |
US8765098B2 (en) | 2010-03-30 | 2014-07-01 | International Business Machines Corporation | Star polymers, methods of preparation thereof, and uses thereof |
US9163107B2 (en) * | 2010-07-26 | 2015-10-20 | Shanghai Jiao Tong University | Cationic polymers formed from amino group-bearing monomers and heterocyclic linkers |
WO2012092341A1 (en) | 2010-12-28 | 2012-07-05 | University Of Rochester | Methods of modifying insulin signaling using biliverdin reductase (bvr) and bvr derived peptides |
US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
CA2839526A1 (en) | 2011-06-23 | 2012-12-27 | Dsm Ip Assets B.V. | Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents |
CN102516534B (zh) * | 2011-11-14 | 2013-11-20 | 上海交通大学 | 可降解为精胺的聚阳离子及其合成方法、纳米颗粒 |
US9694050B2 (en) | 2012-10-21 | 2017-07-04 | University Of Rochester | THY1 (CD90) as a novel therapy to control adipose tissue accumulation |
CA2919828C (en) | 2013-07-30 | 2022-07-19 | Phaserx, Inc. | Block copolymers and their conjugates or complexes with oligonucleotides |
US9757428B2 (en) | 2013-08-16 | 2017-09-12 | University Of Rochester | Designed peptides for tight junction barrier modulation |
WO2015088990A1 (en) | 2013-12-09 | 2015-06-18 | Durect Corporation | Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same |
JP6521981B2 (ja) * | 2013-12-27 | 2019-05-29 | リン、シー−ランLIN, Shi−Lung | 生体内及び体外で核酸類薬物を送達するための新規な糖アルコール類組成物 |
AU2015366355B2 (en) | 2014-12-18 | 2020-05-28 | Dsm Ip Assets B.V. | Drug delivery system for delivery of acid sensitive drugs |
WO2016118697A1 (en) | 2015-01-21 | 2016-07-28 | Phaserx, Inc. | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells |
CN104829786A (zh) * | 2015-05-04 | 2015-08-12 | 中国科学院上海有机化学研究所 | 侧挂天然半乳糖和赖氨酸的阳离子大分子、制备方法及其用途 |
CA2999756A1 (en) | 2015-09-24 | 2017-03-30 | The University Of North Carolina At Chapel Hill | Methods and compositions for reducing metastases |
NZ743320A (en) * | 2015-12-18 | 2019-03-29 | Samyang Biopharmaceuticals | Method for preparing polymeric micelle containing anionic drug |
EP3562510A4 (de) | 2016-12-30 | 2021-01-06 | Genevant Sciences GmbH | Verzweigte peg-moleküle sowie zugehörige zusammensetzungen und verfahren |
WO2019049862A1 (ja) * | 2017-09-05 | 2019-03-14 | 味の素株式会社 | ポリリジン誘導体 |
WO2019129657A1 (en) | 2017-12-28 | 2019-07-04 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Actively targeted polymeric micelles for drug and gene delivery |
US20220249364A1 (en) | 2019-06-05 | 2022-08-11 | University Of Rochester | Designed Inhibitors of Tight Junction Formation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3808531C1 (de) | 1988-03-15 | 1989-07-13 | Eppendorf - Netheler - Hinz Gmbh, 2000 Hamburg, De | |
US5501662A (en) | 1992-05-22 | 1996-03-26 | Genetronics, Inc. | Implantable electroporation method and apparatus for drug and gene delivery |
US5273525A (en) | 1992-08-13 | 1993-12-28 | Btx Inc. | Injection and electroporation apparatus for drug and gene delivery |
EP0712421A1 (de) * | 1993-07-23 | 1996-05-22 | Massachusetts Institute Of Technology | Nanopartikel und mikropartikel aus nichtlinearen hydrophilen-hydrophoben multiblockcopolymeren |
BR9507313B8 (pt) * | 1994-04-08 | 2016-06-07 | Atrix Lab Inc | composição líquida de liberação adequada para a formação de um implante de liberação controlada, sistema polimérico, curativo fílmico microporoso biodegradável, e, precursor de um implante de liberação controlada para a implantação em um indivíduo |
US5752974A (en) * | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
-
1998
- 1998-12-11 JP JP2000523975A patent/JP4570776B2/ja not_active Expired - Lifetime
- 1998-12-11 US US09/209,631 patent/US6210717B1/en not_active Expired - Lifetime
- 1998-12-11 KR KR1020007006208A patent/KR20010032878A/ko active IP Right Grant
- 1998-12-11 BR BR9813548-1A patent/BR9813548A/pt not_active IP Right Cessation
- 1998-12-11 AT AT98963871T patent/ATE412403T1/de not_active IP Right Cessation
- 1998-12-11 WO PCT/US1998/026403 patent/WO1999029303A1/en active IP Right Grant
- 1998-12-11 IL IL13668198A patent/IL136681A0/xx unknown
- 1998-12-11 CN CN98812132A patent/CN1281355A/zh active Pending
- 1998-12-11 DE DE69840175T patent/DE69840175D1/de not_active Expired - Lifetime
- 1998-12-11 AR ARP980106330A patent/AR018528A1/es not_active Application Discontinuation
- 1998-12-11 AU AU19108/99A patent/AU740342B2/en not_active Ceased
- 1998-12-11 ZA ZA9811376A patent/ZA9811376B/xx unknown
- 1998-12-11 EP EP98963871A patent/EP1037611B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2001525357A (ja) | 2001-12-11 |
KR20010032878A (ko) | 2001-04-25 |
AR018528A1 (es) | 2001-11-28 |
IL136681A0 (en) | 2001-06-14 |
ATE412403T1 (de) | 2008-11-15 |
EP1037611A4 (de) | 2006-09-20 |
AU1910899A (en) | 1999-06-28 |
ZA9811376B (en) | 1999-06-28 |
WO1999029303A1 (en) | 1999-06-17 |
US6210717B1 (en) | 2001-04-03 |
EP1037611B1 (de) | 2008-10-29 |
EP1037611A1 (de) | 2000-09-27 |
CN1281355A (zh) | 2001-01-24 |
BR9813548A (pt) | 2000-10-10 |
JP4570776B2 (ja) | 2010-10-27 |
AU740342B2 (en) | 2001-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69840175D1 (de) | Biologisch abbaubare gemischte polymerische mizellen zur genverabreichung | |
DE59608527D1 (de) | Mischmicellen | |
AU2002239324A1 (en) | Biodegradable mixed polymeric micelles for drug delivery | |
DK0914056T3 (da) | Forbedret blandeejektor | |
DE69822337D1 (de) | Mischkatalysatorsystem | |
DE69738238D1 (de) | Epoxy-polysiloxan polymerzusammensetzung | |
DE69716887T2 (de) | Mischer | |
DE69821381D1 (de) | Bioabbaubare thermoplastische zusammensetzung | |
DE69814786D1 (de) | Mischer | |
DE69832705D1 (de) | Mehrfachmethodedirektmischempfänger | |
ID30274A (id) | Campuran serat untuk komposisi enteral | |
DK1011851T3 (da) | Homogeniseringsventil | |
NO20000857D0 (no) | Mikseapparat | |
MD655F1 (ro) | Malaxor Mixer | |
FR2766080B1 (fr) | Mixer plongeant | |
GB2353861B (en) | Mixing system | |
DE69820650D1 (de) | Verbesserter alginatmischer | |
DE29618322U1 (de) | Mischbecher | |
DE29606280U1 (de) | Durchlaufmischer | |
DE69621795D1 (de) | Mischen | |
FR2760978B1 (fr) | Melangeur vertical | |
DE29701364U1 (de) | Dessert-Fertigmischung | |
PL335588A1 (en) | Polymeric mixture | |
ATA16897A (de) | Betonmischung | |
LV12086A (lv) | Jaucejs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1037611 Country of ref document: EP Representative=s name: MUELLER SCHUPFNER & PARTNER PATENT- UND RECHTS, DE |
|
R081 | Change of applicant/patentee |
Ref document number: 1037611 Country of ref document: EP Owner name: SAMYANG BIOPHARMACEUTICALS CORP., KR Free format text: FORMER OWNER: SAMYANG CORP., SEOUL/SOUL, KR Effective date: 20120813 |
|
R082 | Change of representative |
Ref document number: 1037611 Country of ref document: EP Representative=s name: MUELLER SCHUPFNER & PARTNER PATENT- UND RECHTS, DE Effective date: 20120813 |